SYRE
Spyre Therapeutics Inc
$399.66M
Single sell
Discretionary Insider Activity
Date:
06/23/2026
Insiders:
Fairmount Funds Management LLC, director
Prior trend:
23 months of no discretionary insider activity

Summary

A $399.66M single sell for Spyre Therapeutics Inc (SYRE) on 06/23/2026 after 23 months of no discretionary insider activity.

Reports

Action Amount Date Insider Role(s) SEC Filing No
Sell $399.66M 06/23/2026 Fairmount Funds Management LLC + 2 Director 0001104659-26-076967

Stake Changes

Action Insider Role(s) Total Change % Change
Fairmount Funds Management LLC Director unknown unknown

Transactions

Action Amount Date Insider Security Type SEC Code
06/23/2026 Fairmount Funds Management LLC Series B Preferred Stock Non-discretionary Conversion
06/23/2026 Fairmount Funds Management LLC Common Stock Non-discretionary Conversion
Sell $399.66M 06/23/2026 Fairmount Funds Management LLC Common Stock Discretionary Sale

Metadata

Signal ID:
WiBql06zPoRo4cl2
Scanned on:
06/23/2026
Status:
Current